Injection is administered intravenously.
Often a loading dose is given in patients with severe metabolic crisis followed by an equivalent dose over the following 24 hours. It should be administered q3h or q.h. and never less than q6h either by infusion or by intravenous injection. It is recommended that a plasma carnitine level be obtained prior to beginning this parenteral therapy. Weekly and monthly monitoring is recommended as well. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.